STAGE IVA OSTEOSARCOMA AJCC V7
Clinical trials for STAGE IVA OSTEOSARCOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA OSTEOSARCOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IVA OSTEOSARCOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for teens fighting relapsed bone cancer
Disease control OngoingThis study is testing an oral drug called cabozantinib to see if it can control the growth of two aggressive bone cancers, osteosarcoma and Ewing sarcoma, in young patients whose cancer has returned or spread after standard treatment. The drug works by blocking signals tumors nee…
Matched conditions: STAGE IVA OSTEOSARCOMA AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for kids with tough cancers: treatment guided by tumor genetics
Disease control OngoingThis study is testing a personalized approach for children and young adults with advanced cancers that have come back or stopped responding to standard treatments. Doctors first test the genetic makeup of a patient's tumor to look for specific changes. If a matching change is fou…
Matched conditions: STAGE IVA OSTEOSARCOMA AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC